Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

RNA Interference using nanoparticles hits target in human patients

April 29, 2010 Research and Development SiRNA, nanoparticles, rnai

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …
News

Charles River to buy WuXi for $1.6bn

April 27, 2010 Research and Development Charles River, Charles River Laboratories, WuXi, contract research

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
News

Recovery signs, but outsourcing gets more competitive

April 26, 2010 Manufacturing and Production, Research and Development Interphex, contract manufacturing, contract research, contract research organisation

The first green shoots of  recovery in the global economy – assuming of course they are not going to be …
News

Elan looks again at hiving off drug delivery unit EDT

April 22, 2010 Research and Development, Sales and Marketing Elan

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …
News
BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010 Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …
Appointment

Astellas eyes oncology growth

April 21, 2010 Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …
News

GSK’s Arzerra conditionally approved in Europe

April 20, 2010 Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …
News

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010 Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …
News

Trial boost for Merck KGaA’s cladribine

April 19, 2010 Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
News

MedImmune: building a biologics future

April 19, 2010 Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Feature

Action Pharma appoints new chief executive

April 19, 2010 Research and Development Action Pharma, appointment, research and development

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Appointment

Lixisenatide scores in phase III trial

April 15, 2010 Research and Development GLP-1, Lixisenatide, diabetes

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …
News

Roche buys insulin patch company

April 13, 2010 Research and Development Diagnostics, Roche, diabetes

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …
News
AquapharmSimonBest

Dr Simon Best joins Aquapharm as chief executive

April 13, 2010 Research and Development Aquapharm, Aquapharm Biodiscovery, appointment, research and development

Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …
Appointment

Parexel launches software for post-approval trials

April 12, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel has launched a new web-based technology platform for late phase clinical research that it says makes …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026